Drug Shortage Report for POTASSIUM PHOSPHATES INJECTION, USP

Last updated on 2017-05-27 History
Report ID 10000
Drug Identification Number 02139545
Brand name POTASSIUM PHOSPHATES INJECTION, USP
Common or Proper name Potassium Phosphate
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) POTASSIUM PHOSPHATE DIBASIC POTASSIUM PHOSPHATE MONOBASIC
Strength(s) 236MG 224MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 50mL
ATC code B05XA
ATC description I.V. SOLUTION ADDITIVES
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2017-05-12
Actual start date
Estimated end date 2017-06-09
Actual end date 2017-05-26
Shortage status Resolved
Updated date 2017-05-27
Company comments Available at all locations Friday May 26th.
Health Canada comments
Tier 3 Status No
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2017-05-27 English Compare
v5 2017-05-25 French Compare
v4 2017-05-25 English Compare
v3 2017-05-13 English Compare
v2 2017-05-10 French Compare
v1 2017-05-10 English Compare

Showing 1 to 6 of 6